Turkish Journal of Veterinary & Animal Sciences
Volume 38

Number 1

Article 10

1-1-2014

Ractopamine effect on lipid metabolism and GLUT4 amount of
finishing pigs
THIAGO SANTOS ARAUJO
LAURA CRISTINA JARDIM PORTO
ERICA GUILHEN MARIO
LUCIANO JOSÉ PEREIRA
MATHEUS SOARES DA SILVA FERREIRA

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/veterinary
Part of the Animal Sciences Commons, and the Veterinary Medicine Commons

Recommended Citation
ARAUJO, THIAGO SANTOS; PORTO, LAURA CRISTINA JARDIM; MARIO, ERICA GUILHEN; PEREIRA,
LUCIANO JOSÉ; FERREIRA, MATHEUS SOARES DA SILVA; ZANGERONIMO, MARCIO GILBERTO;
NAPIMOGA, MARCELO HENRIQUE; BOTION, LEIDA MARIA; and SOUSA, RAIMUNDO VICENTE DE (2014)
"Ractopamine effect on lipid metabolism and GLUT4 amount of finishing pigs," Turkish Journal of
Veterinary & Animal Sciences: Vol. 38: No. 1, Article 10. https://doi.org/10.3906/vet-1304-65
Available at: https://journals.tubitak.gov.tr/veterinary/vol38/iss1/10

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Veterinary & Animal Sciences by an authorized editor of TÜBİTAK Academic
Journals. For more information, please contact academic.publications@tubitak.gov.tr.

Ractopamine effect on lipid metabolism and GLUT4 amount of finishing pigs
Authors
THIAGO SANTOS ARAUJO, LAURA CRISTINA JARDIM PORTO, ERICA GUILHEN MARIO, LUCIANO JOSÉ
PEREIRA, MATHEUS SOARES DA SILVA FERREIRA, MARCIO GILBERTO ZANGERONIMO, MARCELO
HENRIQUE NAPIMOGA, LEIDA MARIA BOTION, and RAIMUNDO VICENTE DE SOUSA

This article is available in Turkish Journal of Veterinary & Animal Sciences: https://journals.tubitak.gov.tr/veterinary/
vol38/iss1/10

Turkish Journal of Veterinary and Animal Sciences

Turk J Vet Anim Sci
(2014) 38: 54-62
© TÜBİTAK
doi:10.3906/vet-1304-65

http://journals.tubitak.gov.tr/veterinary/

Research Article

Ractopamine effect on lipid metabolism and GLUT4 amount of finishing pigs
1,

2

3

1

Thiago Santos ARAÚJO *, Laura Cristina JARDIM PORTO , Érica GUILHEN MARIO , Luciano José PEREIRA ,
1
1
4
Matheus Soares DA SILVA FERREIRA , Márcio Gilberto ZANGERÔNIMO , Marcelo Henrique NAPIMOGA ,
3
1
Leida Maria BOTION , Raimundo Vicente DE SOUSA
1
Department of Veterinary Medicine, Physiology and Pharmacology Sector, Federal University of Lavras, Lavras, Minas Gerais, Brazil
2
Department of Food Science, Nutrition Sector, Federal University of Lavras, Lavras, Minas Gerais, Brazil
3
Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte,
Minas Gerais, Brazil
4
Laboratory of Immunology and Molecular Biology, São Leopoldo Mandic Institute and Research Centre, Campinas, São Paulo, Brazil
Received: 27.04.2013

Accepted: 24.07.2013

Published Online: 18.12.2013

Printed: 20.01.2014

Abstract: Ractopamine (RAC) causes fat deposition and/or fatty acid synthesis reduction and increases the rate of protein synthesis
and muscle growth. However, there are few scientific studies detailing the mechanism of action of RAC and its possible metabolic
pathways in swine. The objective of this study was to evaluate the effect of RAC on lipid metabolism of finishing pigs. Subcutaneous and
retroperitoneal fat, muscle, and blood samples were collected at slaughter. Forty pigs were fed different RAC levels (ppm): 0, 5, 10, 15,
and 20. RAC did not affect lipoprotein lipase activity in any of the tissues. There were no changes in insulin levels, but a linear increase
in serum triacylglycerol, total cholesterol, and HDL-cholesterol (HDL-c) was seen. The insulin-dependent glucose transport (GLUT4)
and fatty acid synthase amounts present in animals’ adipose tissue did not differ, but the muscle GLUT4 presented a negative quadratic
effect. The smallest GLUT4 amount (0.959) was estimated for 15.5 ppm of RAC. Serum glucose increased linearly, while a linear decrease
in glycogen content was detected. The results indicate that RAC acts upon lipid metabolism in order to stimulate lipolysis, while there
are changes in carbohydrate metabolism that might support lean growth in these animals.
Key words: β-Adrenergic agonist, lipoprotein lipase, fatty acid synthase, GLUT4

1. Introduction
Fat deposition in animals can be beneficial or undesirable,
depending on the quantity and location. In pork
production, the understanding of lipid metabolism and its
regulatory mechanisms contributes to the development of
strategies capable of altering the fat deposition in different
animal tissues, thereby improving the meat quality;
supplementation with ractopamine (RAC) is one such
example (1).
It is believed that RAC, a β-adrenergic receptor agonist,
can control the fat in pigs through important metabolic
pathways related to fat tissue deposition and fat release
by activating specific β-adrenergic receptors as a result
of its chemical structure and pharmacological properties
that are similar to those of catecholamines. This helps to
produce carcasses with lower fat levels, resulting from the
better nutrient partitioning that supports muscle growth
rather than fat deposition (2).
Some of the effects of RAC supplementation on
lipid metabolism in pigs include the regulation of gene
* Correspondence: thiagobiocouto@gmail.com
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expression related to the breakdown of body fat and the
genes that regulate enzymes involved in lipogenesis (3,4).
As other studies are still necessary to help to understand
the possible pathways of this drug in pigs, metabolically
important enzymes, such as lipoprotein lipase, also require
further investigations in this animal model. Therefore,
the aim of this study was to evaluate enzymes from fat
and muscle cells related to lipid synthesis and glucose
metabolism as well as serum biochemical parameters of
finishing pigs fed different levels of RAC.
2. Materials and methods
2.1. Experimental procedure
All animals were cared for in accordance with the principles
promulgated by ethical guidelines and the experimental
protocol was approved by the Ethics Committee in Animal
Experimentation of the Federal University of Lavras.
Forty commercial crossbred pigs (TOPIGS) from
the Swine Experimental Centre of the Animal Science
Department, Federal University of Lavras, barrows and
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gilts, were used to collect samples of subcutaneous (SAT)
and retroperitoneal (RPAT) adipose tissues, the longissimus
dorsi (MT), and blood. Throughout the experimental
period, the animals were housed in individual pens with a
concrete floor (2.3 × 1.5 m) equipped with semiautomatic
feeders and access to water ad libitum. Animals were fed

twice daily at 0700 and 1600 hours. The treatments were:
control diet formulated with corn and soybean meal,
without RAC; diet + 5 ppm RAC; diet + 10 ppm RAC;
diet + 15 ppm RAC, and diet + 20 ppm RAC. Table 1
presents the composition and the percentage values of the
experimental diets.

Table 1. Composition and percentage values of experimental diets for finishing pigs fed with different levels of
ractopamine.
Experimental diets
0 ppm

5 ppm

10 ppm

15 ppm

20 ppm

Corn

71.43

71.43

71.43

71.43

71.43

Soybean meal

22.73

22.73

22.73

22.73

22.73

Soy oil

2.50

2.50

2.50

2.50

2.50

Dicalcium Phosphate

0.92

0.92

0.92

0.92

0.92

Calcium Carbonate

0.67

0.67

0.67

0.67

0.67

Salt

Ingredient composition (%)

0.36

0.36

0.36

0.36

0.36

1

0.10

0.10

0.10

0.10

0.10

Vitamin premix2

0.10

0.10

0.10

0.10

0.10

DL-Methionine 99%

0.16

0.16

0.16

0.16

0.16

L-Lysine HCL 78%

0.35

0.35

0.35

0.35

0.35

L-Threonine 98%

0.17

0.17

0.17

0.17

0.17

Clay

0.490

0.465

0.440

0.415

0.390

0.02

0.02

0.02

0.02

0.02

0.00

0.025

0.05

0.075

0.10

Crude protein (%)

16.20

16.20

16.20

16.20

16.20

ME (kcal/kg)

3310

3310

3310

3310

3310

Digestible Lysine (%)

1.003

1.003

1.003

1.003

1.003

Digestible methionine (%)

0.400

0.400

0.400

0.400

0.400

Digestible threonine (%)

0.717

0.717

0.717

0.717

0.717

Available phosphorus (%)

0.263

0.263

0.263

0.263

0.263

Calcium (%)

0.559

0.559

0.559

0.559

0.559

Mineral premix

Tylan3
Ractosuin

4

Nutritional composition

1
Composition, per kg: calcium: 98.800 mg; cobalt: 185 mg; iron: 26.650 mg; copper: 15.750 mg; iodine: 1.470
mg; manganese: 41.850 mg; zinc: 77.999 mg.
2
Composition, per kg: folic acid: 116.55 mg; pantothenic acid: 2333.5 mg; biotin: 5.28 mg; niacin: 5.600 mg;
pyridoxine: 175 mg; riboflavin: 933.3 mg; thiamine, 175 mg; vitamin A: 1,225,000 UI; vitamin D3: 315,000 UI;
vitamin E: 1.400 mg; vitamin K3: 700 mg; vitamin B12: 6.825 mg; selenium: 105 mg; antioxidants: 1.500 mg.
3
Antibiotic made from granulate tylosin.
4
Ractopamine hydrochloride 2.05%.
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2.2. Sample collection
The samples of SAT, RPAT, MT, and blood were collected at
the moment of slaughter, which occurred at the end of the
28-day experimental period. Slaughtering was performed
after electrical stunning in a commercial facility, according
to the rules of the Brazilian Federal Inspection Service. All
slaughtered animals were fasted for 12 h prior to slaughter.
Fragments of SAT and RPAT with a thickness of at least
1 cm and a depth of 1 cm were collected in duplicate during
evisceration immediately after slaughter. Fragments of MT
were collected in similar sizes as adipose tissue, also in
duplicate, from the left side of the carcasses of the pigs.
Both procedures were carried out carefully using sterile
instruments. Each fragment collected was stored in
resistant plastic bags, individually identified with labels
and immediately frozen in liquid nitrogen. The collected
tissue was divided and transported in liquid nitrogen, and
then stored in a freezer (–80 °C) until analysis.
The blood was collected in duplicate during bleeding,
which was performed by cutting the great vessels of
the neck, with the animals positioned vertically and
suspended by one of their hind limbs. Blood sample
storage was done in test tubes with no anticoagulant, and
samples were individually identified. The material was
kept under refrigeration (2 °C to 8 °C) during transport,
which lasted 30 min. In the Physiology and Pharmacology
Sector, samples were centrifuged at 1000 × g for 15 min to
separate serum, which was stored at –20 °C in polyethylene
centrifuge tubes for later analysis of the following metabolic
parameters: glucose (GLU), total cholesterol (TC), HDLcholesterol (HDL-c), and triacylglycerol (TAG). Serum
used for insulin (IN) measurement assay remained stored
in a freezer at –80 °C.
2.3. Total lipoprotein lipase activity analysis
In order to perform this analysis, fragments weighing 150
mg of SAT, RPAT, and MT were homogenized in buffer
containing detergents (0.2 M Tris/HCl, pH 8.3, 5000
UI/mL heparin, 1 mg/mL BSA, and 5 mg/mL sodium
deoxycholate) (5) and total lipoprotein lipase (LPL) activity
was measured using a lecithin emulsified substrate (6)
containing [9,10-3H]-triolein and plasma from rats fasted
24 h as a source of apoCII. The reaction was quenched with
extraction mixture (7) and [3H] fatty acids released were
quantified by liquid scintillation spectroscopy (Beckman
LS 7600). The enzyme activity was expressed as moles of
[3H] fatty acid released per milligram of evaluated tissue
per minute.
2.4. Glycogen content determination
To measure the glycogen content, glycogen extraction from
samples of 200 mg of MT was performed in boiling water
for 1 h using a KOH solution (30%), followed by addition
of saturated Na2SO4 and ethanol (100%) to precipitate
the glycogen from alkaline digestion. The material was
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centrifuged at 978 × g for 10 min, and then the glycogen
was rinsed with distilled water and precipitated again
using 100% ethanol followed by centrifugation. The
glycogen precipitate was dissolved in 10 mL of distilled
water and the final solution was stored in 15-mL tubes.
A mixture of anthrone was carefully added to a 1-mL
aliquot of the final dilution with subsequent heating of the
samples in boiling water for 10 min. The absorbance was
read in a spectrophotometer at 620 nm. Different glucose
concentrations were used to plot a calibration curve.
2.5. Western blotting analysis
Semiquantitative analyses were performed only on barrow
samples, since these animals showed a better response
pattern to RAC. Proteins were obtained from SAT and
MT samples using a lysis buffer (1% Triton X-100, 100
mM Tris/HCl, pH 8.0, 10% glycerol, 5 mM EDTA, 200
mM NaCl, 1 mM DTT, 1 mM PMSF, 25 mM NaF, 2.5 mg/
mL leupeptin, 5 mg/mL aprotinin, and 1 mM sodium
orthovanadate). Lysates were centrifuged at 10,000 × g for
10 min at 4 °C and quantified using the Bradford assay
reagent from Bio-Rad (Hercules, CA, USA).
Twenty micrograms of protein from the SAT and
MT was separated by 10% sodium dodecyl sulfate–
polyacrylamide gel electrophoresis and transferred to a
nitrocellulose membrane (Bio-Rad). A molecular weight
standard (Bio-Rad) was run in parallel to estimate
molecular weight. Membranes were blocked overnight at 4
°C in Tris-buffered saline-Tween (TBST; 20 mM Tris-HCl,
pH 7.5, 500 mM NaCl, 0.1% Tween 20) containing 5%
dried milk. After blocking, membranes were incubated at
4 °C overnight with anti-ICAM-1 (1:1000), anti-RANKL
(1:1000), anti-OPG (1:2000), or α-tubulin (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), used as an internal
control (1:1000), diluted in TBST containing 5% dried
milk for the analyses of gingival proteins. Membranes
were then incubated at room temperature for 60 min with
secondary antibody conjugated with peroxidase (1:5000)
diluted in TBST containing 5% dried milk.
Finally, the bands recognized by the specific antibody
were visualized using a chemiluminescence-based ECL
system (Amersham Biosciences, Piscataway, NJ, USA)
and exposed to an X-ray film for 30 min (Eastman Kodak,
Rochester, NY, USA). A computer-based imaging system
(Image J, Bethesda, MD, USA) was used to measure the
intensity of optical density of bands.
2.6. Biochemical parameters
GLU, TC, and HDL-c concentrations from serum were
respectively quantified by the glucose oxidase, cholesterol
oxidase, and modified PEG 6000 methodologies using
Doles (Goiânia, GO, Brazil) enzymatic assays according
to the protocol of the manufacturer. TAG was quantified
by the Enzyme-Trinder method using the LABTEST
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2.7. Statistical analysis
The data were analyzed in a randomized block design with
5 treatments and 8 replications. After testing for normality
and homogeneity of variances (Shapiro–Wilk and Levene
test, respectively), data were subjected to analysis of
variance using SPSS 17.0 for Windows. Multiple regression
analyses through the third degree were performed. The
results were considered significant when P < 0.05.
3. Results
There was no significant difference among the different
levels of RAC on LPL total activity on blood vessels around
SAT, RPAT, or MT (Table 2) of pigs.
A linear decrease (P < 0.01) in the amount of glycogen
stored in skeletal muscle tissue of the pigs was observed
with increasing doses of dietary RAC after 28 days of
treatment (Figure 1).
Figure 2 shows the bands of insulin-dependent glucose
transporter (GLUT4) (54 kDa) as well as the enzyme

88
M g g ly cog en/g t issu e

(Lagoa Santa, MG, Brazil) enzymatic test, according to
the manufacturer’s protocol. The IN concentration was
quantified by ELISA Millipore insulin kit (Millipore, St
Charles, MO, USA) according to manufacturer’s methods.

86
84
82
y = –0.4054Rac + 86.937
R² = 0.9411

80
78

0

5

10
RAC (ppm)

15

20

Figure 1. Muscle glycogen versus ractopamine (RAC) levels on
diets for commercial hybrid finishing pigs, barrows and gilts.

fatty acid synthase (FAS) (250 kDa) in SAT of barrows
fed different levels of RAC. Figure 3 shows the bands of
54 kDa GLUT4 in the muscle tissue of barrows fed with
different levels of RAC.
As demonstrated in Table 3, GLUT4 and FAS in SAT
were not affected by different levels of RAC in the diet.
Regarding GLUT4 in skeletal muscles, there was a negative
quadratic effect (P < 0.01) as the levels of RAC in the diet

Table 2. Lipoprotein lipase total activity (LPL) on subcutaneous adipose tissue (SAT), retroperitoneal adipose tissue (RPAT), and muscle
tissue (MT) and muscle glycogen content and biochemical parameters of finishing pigs, barrows and gilts, fed with different levels of
ractopamine (RAC).
RAC (ppm)

CV1

Regression P

0.018

22.39

-

0.114

0.022

0.022

13.00

-

0.197

0.029

0.029

0.029

13.48

-

0.542

84.84

84.00

80.97

81.08

6.23

Linear

**

83.80

92.24

98.11

99.46

99.90

11.88

Linear

*

TC (mg dL–1)

68.85

77.33

81.17

87.29

90.50

12.95

Linear

**

HDL-c (mg dL–1)

35.34

38.00

40.82

42.29

43.23

7.08

Linear

***

TAG (mg dL )

50.07

56.27

56.69

61.41

63.89

11.25

Linear

**

IN (ng mL )

0.116

0.107

0.106

0.100

0.094

33.03

-

0.766

0

5

10

15

20

SAT

0.024

0.023

0.021

0.019

RPAT

0.025

0.023

0.023

MT

0.026

0.028

87.40

GLU (mg dL–1)

LPL activity2

Muscle glycogen content
Longissimus dorsi3
Biochemical parameters

–1

–1

GLU = Serum glucose; TC = total cholesterol; HDL-c = HDL cholesterol; TAG = triacylglycerol; IN = insulin.
1
Coefficient of variation (%).
2
Moles of fatty acid released per milligram of tissue per minute.
3
Milligrams of glycogen per gram of tissue.

57

ARAÚJO et al. / Turk J Vet Anim Sci
RAC levels
GLUT4

0 ppm

5 ppm

10 ppm

15 ppm

20 ppm

FAS

Figure 2. Western blotting of proteins GLUT4 and FAS in subcutaneous adipose tissue
of commercial hybrid barrows fed with different levels of ractopamine (RAC).

RAC levels

0 ppm

5 ppm

10 ppm

15 ppm

20 ppm

GLUT4

Figure 3. Western blotting of protein GLUT4 in muscle tissue (longissimus dorsi) of
commercial hybrid barrows fed with different levels of ractopamine (RAC).
Table 3. Semiquantitative analysis by western blotting of the insulin-dependent glucose transporter (GLUT4) and of the enzyme fatty
acid synthase (FAS) on subcutaneous adipose tissue (SAT) and muscle tissue (longissimus dorsi) of commercial hybrid barrows fed with
different levels of ractopamine (RAC).
RAC (ppm)

CV1

Regression

P

0.595

11.57

-

0.263

0.610

0.655

16.21

-

0.450

1.020

1.010

8.91

Quadratic

**

0

5

10

15

20

GLUT42

0.780

0.765

0.696

0.655

FAS3

0.495

0.680

0.660

1.785

1.325

1.025

SAT

Longissimus dorsi
GLUT42

Coefficient of variation (%).
Ratio GLUT4/α-tubulin; units are relative density.
3
Ratio FAS/α-tubulin; units are relative density.
1
2

4. Discussion
LPL is an essential enzyme acting on the direct control
of triacylglycerol between muscle and adipose tissue,
increasing lipid storage or providing energy as fatty
acids for muscle growth. Evaluating the activity of this
enzyme can be a valid tool for the study of the anabolic
fat pathway, especially in adipose tissue (8). Based on the
effects of catecholamines on LPL activity in adipose and
muscle tissue, with a decrease and increase, respectively,
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2.0
1.8

GLUT4 = 0.0034Rac 2 - 0.1054Rac + 1.7747
R² = 0.988

1.6
GLUT4

increased; thus, the smallest amount of GLUT4 (0.959)
was estimated for 15.5 ppm of RAC in the diet (Figure 4).
RAC did not affect serum levels of IN (Table 2). GLU,
TC, HDL-c, and TAG showed linear increases (P <0.05, P
<0.01, P <0.001, and P <0.01, respectively) as RAC levels
increased (Figure 5).

1.4
1.2
1.0
0.8
0.6

0

5

10
RAC (ppm)

15

20

Figure 4. Semiquantitative analyses by western blotting of the
insulin-dependent glucose transporter (GLUT4) on muscle tissue (longissimus dorsi) of commercial hybrid barrows fed different levels of ractopamine (RAC). Results presented as ratio of
GLUT4/α-tubulin; units are relative density.
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TC = 1.0652Rac + 70.376
R 2 = 0.975
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0
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65
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0
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C
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40
38
HDL –c = 0.4014Rac + 35.922
R 2 = 0.958

36
34
0

5

10
RAC (ppm)

15
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RAC (ppm)

TAG (mg dL–1)

HDL–c (mg dL–1)

46

10

15

D

57
53
TAG = 0.6556Rac + 51.11
R 2 = 0.9479

49
45
20

0

5

10

15

20

RAC (ppm)

Figure 5. Serum glucose (GLU) (a), total cholesterol (TC) (b), HDL cholesterol (HDL-c) (c), and triacylglycerol (d)
versus levels of ractopamine (RAC) in diets of commercial hybrid finishing pigs, barrows and gilts.

found by Fonseca-Alaniz et al. (9) and Goldberg et al.
(10), it was expected that swine LPL activity after RAC
supplementation could also provide the same change;
however, this effect was not observed, probably because
RAC does not act directly on the LPL activity of pigs.
Another valid parameter for the study of the anabolic
pathway, FAS, was also evaluated in this experiment. As
previously reported, RAC did not alter the amount of FAS
present in the pigs’ subcutaneous fatty tissue; however, a
reduction in the amount of FAS mRNA in the same tissue
was observed in pigs supplemented with 20 ppm RAC for
28 days (4) as well as for 52 days (3). None of the work
addressed methodologically resembles this experiment;
therefore, it must be taken into account that the answers
herein obtained may have varied from the others due to
the animals used, time of exposure to agonist, and level
administered.
Therefore, it is thought that supplementation of pigs
with RAC alters the lipid metabolism of the animals,
resulting in the stimulation of lipolysis instead of blocking
lipogenesis, although the adipose tissue of these animals has

a lower concentration of lipolytic β3-adrenergic receptors
(11). This may be a likely explanation for the decrease in
fat deposition in the carcass of pigs supplemented with the
additive found by several authors (2,12). In fact, Peterla
and Scanes (13) found in vitro that adipocytes from pigs
treated with RAC showed an increased release of glycerol.
According to Adeola et al. (14), when RAC improves
performance and carcass composition of pigs and also
induces change in the metabolism of the animals, this
increases the utilization of fat for oxidation and enhances
the responsiveness of the adipose cells to lipolytic stimuli.
Changes in lipid metabolism at different levels have
a direct impact on serum levels of triacylglycerol-rich
lipoproteins and cholesterol-rich lipoproteins (15). Hoshi
et al. (16) found that pigs supplemented with 20 ppm of
RAC showed a linear increase of TC, TAG, and HDL-c.
Similarly, the same parameters were found to be increased
in this study. Probably as a result of other mechanisms
not identified with this research, RAC may have caused
a decrease in the uptake of chylomicron remnants and
circulating lipoproteins, as well as cholesterol uptake by
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the liver, which may have affected the levels of serum
TAG and TC, respectively, as well as HDL-c levels (greater
fraction present in the pig).
While RAC is able to activate the lipolytic pathway in
the adipose tissue of pigs, insulin has a lipogenic role in
this tissue (17). Although Dunshea and King (18) found
that pigs supplemented with RAC presented decreased
basal insulin levels, this effect was not demonstrated in this
experiment. It is possible that RAC may have decreased
sensitivity to insulin and/or insulin binding to adipocytes
of supplemented pigs, which is similar to results found
previously in in vitro studies (19). Additionally, the liver,
in response to stimulation by the agonist, may present
reduced removal of insulin, which could have helped with
the maintenance of high levels of this hormone (20).
Measuring the concentration of a metabolite in plasma
does not necessarily indicate a rate of metabolic change
that occurs in a specific tissue, since the circulating
concentrations of these metabolites depend on several
factors such as feed intake, production rate, uptake rate and
release rate for plasma, intracellular reuse, blood flow, and
the complex interplay of hormones (8,14). Thus, all changes
observed in this experiment must not be uniquely suggested
as the result of a single event, as they may also have arisen
from metabolic complexes and integrated events within
lipid metabolism of the animal, such as, for example, in
response to changes in carbohydrate metabolism.
In addition to acting in important metabolic pathways,
RAC is known to be related to lipid and protein metabolism;
it has also been shown to have an effect on carbohydrate
metabolism of supplemented animals, and thus integrated
redirects the nutrients present in the diet favoring the
synthesis of proteins at the expense of fat deposition in
the carcass (12,21). As with catecholamines, the use of
synthetic β-agonists may cause increased concentrations
of glucose and nonesterified fatty acids in the plasma of
supplemented animals; these changes have already been
reported (14,22).
Therefore, hyperglycemia can be considered a mark
of metabolic response due to the use of catecholamines
and their similarities to β-adrenergic agonists, which is
in contrast to the observations of Dunshea and King (18);
this effect was demonstrated in the current experiment.
The pigs supplemented with RAC showed a maximum
increase in serum glucose of approximately 19%. These
results are similar to those obtained by Mersmann (8),
whose experiment, which was designed to evaluate the
acute metabolic effects of supplementation with the same
agonist in the diet of pigs, showed an increase in volume
as a result of glucose by 24%; Vandenberg et al. (23) also
found similar results when working with fish. It is believed
that the stimulation of hepatic β2-adrenergic receptors
by RAC may have resulted in increased catabolism
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of glycogen (glycogenolysis and/or gluconeogenesis,
indirectly), providing a higher plasma level of glucose
(24), presumably to support the increase verified by
several authors in protein deposition that occurs in the
skeletal muscle of these animals during supplementation
with RAC (2,12).
The glycogenic effect previously discussed following
the administration of catecholamines can also be analyzed
in the skeletal muscle (21); this work showed a decrease
in the glycogen content of pigs supplemented with RAC.
The results demonstrated here for serum glucose and
muscle glycogen content can provide support for the
changes found by Gunawan et al. (21) with regards to the
expression of glycogen synthase in their experiment with
pigs. Initially, the increasing availability of glucose into the
circulation due to the mobilization of energy reserves from
the liver stimulates the expression of glycogen synthase
(GS). With the chronic administration of RAC, the need
for energy associated with muscle growth increases and
is continuously stimulated by the additive. From this
moment, it would no longer be necessary to maintain high
levels of GS in muscle cells that suffered down-regulation
of its gene with the concomitant necessity of breaking
the muscle glycogen stores by the action of the enzyme
glycogen phosphorylase. Further studies in this field are
encouraged in order to clarify this hypothesis.
Supplementation with RAC increases lipolysis
by binding β-adrenergic receptors present in the
adipocyte membrane, with the subsequent activation
of a signaling cascade that involves the synthesis of
cAMP and the subsequent activation of hormonesensitive lipases by protein kinase A (17). Additionally,
it was shown that protein kinase A, through increased
serine phosphorylation, shows inhibitory effects on
several reactions involved in the process of converting
glucose to triacylglycerol and the subsequent storage
(25). As proposed by Liu et al. (25), it was expected that
pigs supplemented with RAC would show a decreased
lipogenesis rate with a consequent decrease in the activity
of enzymes involved in lipid synthesis and the glucose
transporter GLUT4, which participates in the metabolism
of lipids and carbohydrates. However, in contrast to the
results of Halsey et al. (4) and Reiter et al. (3), this result
was obtained only with the amount of GLUT4 present in
the skeletal muscle tissue of animals (Figure 4). Halsey et
al. (4) found that 28 days of supplementation with RAC
was able to decrease the amount of GLUT4 mRNA present
in the adipose tissue of the animals. Reiter et al. (3), while
increasing the time of exposure to the agonist (52 days),
were able to obtain similar results for GLUT4 mRNA
present in the adipose tissue and further proved that the
same effect (decrease) was also found in skeletal muscle
tissue.
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The fact that the amount of GLUT4 and FAS in adipose
tissue of pigs did not vary between treatments does not
indicate that RAC cannot be an agonist in the adipose
tissue of these animals. The characteristic effects of RAC
are already well demonstrated in both in vitro and in vivo
studies (19,26). It is probable that RAC supplementation
for 28 days induced the down-regulation of β-adrenergic
receptors present in adipose tissue of the animals, causing a
decrease in the β-adrenergic response. It is well established
that the long-acting agonist can induce desensitization of
β-adrenergic receptors, with the subsequent sequestration
of the agonist-receptor complex to the intracellular
environment and the appearance of the down-regulation
phenomenon (27). All of these processes cause a reduction
in the amount of β1, β2, and β3 receptors on the membrane
(28). According to Spurlock et al. (29), either desensitization
does not occur in muscle tissue or down-regulation
processes have little influence on this tissue, since the
number of β-receptors in the skeletal muscle of pigs fed
RAC for 28 days did not decrease in their experiment. The
results obtained from this study confirm the hypothesis of
the authors, given that there was a decrease in the amount
of glucose transporters in the supplemented animals.
Additionally, it is known that both genes and lipogenic
enzymes are extremely sensitive to the energy status of the
animal (4). Before slaughter in this experiment, the animals
were fasted for 12 h. Thus, SAT, RPAT, and MT were obtained
after slaughter and may not reflect the actual scenario of the
amount of active enzymes in the adipose tissue of living
animals. In the works of Halsey et al. (4) and Reiter et al. (3),
pigs were slaughtered without any period of food deprivation,

which may be reflected in the results obtained by these
authors. Liu et al. (25), however, did not explain whether
the animals in their experiment were fasted or not, but their
results showed that RAC did not affect the amount of GLUT4
mRNA present in the adipose tissue of the animals.
Changes in blood metabolites and lipid and
carbohydrate metabolism observed in the present study
and discussed based on observations previously published
by other authors show that some of the components of
the breakdown of nutrients caused by RAC result in fat
reduction and an increase in muscle mass and production
efficiency. It is concluded that RAC, when administered
to swine in the finishing phase, acts on adipose tissue
metabolism in order to stimulate lipolysis, and that there
are also changes in carbohydrate metabolism that will
support the mass lean growth in supplemented animals.
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